跳至主要内容
临床试验/NCT02981485
NCT02981485Unknown2 期

Fat Grafting Used for the Treatment of Breast Cancer Related Lymphedema in China

Peking Union Medical College1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2016年12月1日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
30
试验地点
1
主要终点
Change in arm volume

研究概览

简要总结

Breast cancer related lymphedema (BRCL) is a common complication following breast cancer treatment. The incidence of BRCL ranges from 6-50%, depending on the surgical procedure in the axilla and the type of the radiation therapy. BRCL can causes cosmetic deformities, impaired physical mobility, mental discomfort, reduced quality of life and erysipelas. Therapy of BRCL is divided into conservative and operative methods. However, all the above method has some shortcomings. It is urgent to investigate new approaches to treat BRCL. In this study, fat grafting is to be used for the treatment of BRCL, and the efficacy and safety of this method will be also assessed.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Breast cancer diagnosis regardless of the date of operation and identified unilateral arm lymphedema Stage Ⅱ of lymphedema according to the standard of International Society of Lymphology The patient is able to read, understand, and complete questionnaires. Completed radiotherapy and/or chemotherapy at least 2 months prior to inclusion The patient understands the nature and purpose of this study and the study procedures and has signed informed consent.

排除标准

  • Relapse of breast cancer Untreated infection Untreated heart failure Untreated renal failure Untreated deep venous thrombosis in the arm Iodine allergy Pregnancy Psychiatric disorders

结局指标

主要结局

Change in arm volume

时间窗: Baseline, 3 months, 6months and 12 months

All the patients who received treatment are scanned by 3 dimensional camera, then the volume measurement of the affected and normal arm is managed by software

次要结局

  • Change in tissue edema(Baseline, 3 months, 6months and 12 months)
  • The function of the lymphatic vessel(Baseline, 3 months, 6months and 12 months)
  • Side effects of treatment(Baseline, 3 months, 6months and 12 months)
  • Change in quality of life(Baseline and 12 months)

研究者

发起方
Peking Union Medical College
申办方类型
Other
责任方
Principal Investigator
主要研究者

Minqiang Xin

Principal Investigator

Peking Union Medical College

研究点 (1)

Loading locations...

相似试验